Cytokinetics (CYTK)

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

O preço atual da ação Cytokinetics, Incorporated Common Stock (CYTK) é de , refletindo uma variação de NaN% desde o abriu. A capitalização de mercado da empresa é de 7,51 mM $, com um volume de negociações diário de ações. O preço de fechamento anterior foi .

Pronto para começar? Siga os passos abaixo ou leia nosso guia sobre como comprar Cytokinetics ações na Kraken a partir de 10 $.